Jill Wilson
About Jill Wilson
Jill Wilson is an Oncology Sales Specialist at Bristol-Myers Squibb, with over 9 years of experience in the role and a background in hematology consulting.
Current Role at Bristol-Myers Squibb
Jill Wilson is currently serving as an Oncology Sales Specialist at Bristol-Myers Squibb. Based in multiple Michigan locations including Ann Arbor, Saginaw, and Flint, as well as Toledo, she brings her specialized expertise in oncology to her role. Jill has been with Bristol-Myers Squibb for over nine years, starting her tenure in March 2014. Her responsibilities include promoting and educating healthcare professionals about oncology products and advancing the company's mission in cancer care.
Previous Experience at Genzyme Sanofi
Before joining Bristol-Myers Squibb, Jill Wilson worked at Genzyme Sanofi as a Senior Hematology Consultant. She served in this capacity for 16 years, from 1998 to 2014, covering regions in Southeast Michigan and Northern Ohio. During her time at Genzyme Sanofi, she focused on hematology, leveraging her deep knowledge to support the treatment and management of blood disorders.
Educational Background in Nursing
Jill Wilson completed her Bachelor of Science (B.S.) in Registered Nursing/Registered Nurse at the University of Windsor. Her academic journey spanned from 1985 to 1990, equipping her with foundational knowledge and skills in the nursing field. This educational background has been instrumental in her subsequent roles in oncology and hematology, providing her with a solid understanding of patient care and medical practices.
Expertise in Oncology and Hematology
With over two decades of experience in the pharmaceutical industry, Jill Wilson has developed extensive expertise in oncology and hematology. Her current role at Bristol-Myers Squibb and previous long-term tenure at Genzyme Sanofi highlight her depth of knowledge and commitment to advancing treatments in these specialized fields. Jill's broad geographic coverage and persistent focus reflect her dedication to improving healthcare outcomes for patients with cancer and blood disorders.